speb/financial-data huggingface dataset:
Financial ratios for 2659.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 134734109.5890411
Buffett classification: The Gruesome
Shares outstanding: 152955550
Book value: 136421369.86301368
Debt to equity: 0.2061089934891493
Current ratio: 3.391818825771667
Quick ratio: 3.3677910218059326
Retained earnings: -91460821.91780822
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2659.HK — annual report dated 2024-12-31
Total revenue: 843835.6164383562
Gross profit: 687671.2328767123
Operating income: -49244520.54794521
Net income: -49922328.76712329
Capital expenditures: 16180821.91780822
Operating cash flow: -30106986.301369864
Depreciation & amortization: 4402191.780821918
Net tangible assets: 134734109.5890411
Owner earnings: -61700958.90410959
Return on net tangible assets (%): -45.794609169353336
Buffett classification: The Gruesome
Shares outstanding: 152955550
Book value: 136421369.86301368
Debt to equity: 0.2061089934891493
Current ratio: 3.391818825771667
Quick ratio: 3.3677910218059326
Interest coverage ratio: -78.90364354697103
COGS to revenue (%): 18.506493506493506
R&D to revenue (%): 4198.62012987013
SG&A to revenue (%): 324.25324675324674
Free cash flow (dilution-adjusted): -67288630.1369863
Retained earnings: -91460821.91780822
Inventory turnover: 0.24178154825026513
Receivables turnover: 43.68794326241135
Capitalized R&D asset: 48035252.33608847
ROCI (R&D-adjusted, %): -15.34196137934626
Rosenberg metric: -0.014140907919793196
FCF margin (%): -7974.1396103896095
Revenue growth (%): -13.424657534246565
Rule of 40 score: -7987.564267923856
Financial ratios for 2659.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 122400000
Buffett classification: The Gruesome
Shares outstanding: 152955550
Book value: 124070432.35704325
Debt to equity: 0.27678749079627013
Current ratio: 2.085097439816584
Quick ratio: 2.06647097648244
Retained earnings: -118655509.06555091
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2881.HK — annual report dated 2022-12-31
Total revenue: 450263793.1034483
Gross profit: 100470977.01149425
Operating income: 65683620.68965517
Net income: 48918103.448275864
Capital expenditures: 11932614.942528736
Operating cash flow: 21316379.310344826
Depreciation & amortization: 17051436.781609196
Net tangible assets: 103812356.32183908
Owner earnings: 54036925.28735632
Return on net tangible assets (%): 52.05249856754145
Capex to operating income (%): 18.16680447460178
Buffett classification: The Great
Shares outstanding: 93300000
Book value: 104325718.39080462
Debt to equity: 1.0757849738399434
Current ratio: 0.7096869748450793
Quick ratio: 0.446714827749186
Effective tax rate (%): 20.39327550328509
Interest coverage ratio: 14.734674144266098
COGS to revenue (%): 77.68619672503604
R&D to revenue (%): 4.244031914880039
SG&A to revenue (%): 1.012656692947557
Free cash flow (dilution-adjusted): 9305316.091954025
Retained earnings: 89651293.10344827
Inventory turnover: 7.596575147980692
Receivables turnover: 22.006348047132846
Capitalized R&D asset: 19109339.08045977
ROCI (R&D-adjusted, %): 50.93312406122267
FCF margin (%): 2.066636543839563
Rule of 40 score: 2.066636543839563
Financial ratios for 2881.HK — annual report dated 2023-12-31
Total revenue: 376526441.6315049
Gross profit: 46380450.07032349
Operating income: 17644303.797468353
Net income: 10253445.850914204
Capital expenditures: 4920815.752461322
Operating cash flow: 22868635.724331927
Depreciation & amortization: 18563291.139240507
Net tangible assets: 73918565.40084387
Owner earnings: 23895921.23769339
Return on net tangible assets (%): 32.32736066793389
Capex to operating income (%): 27.888976572526325
Buffett classification: The Good
Shares outstanding: 93300000
Book value: 74489029.53586498
Debt to equity: 1.7845159804160364
Current ratio: 0.5852259228174946
Quick ratio: 0.38466204713162866
Effective tax rate (%): 23.048829403196187
Interest coverage ratio: 3.8862178990737584
COGS to revenue (%): 87.68202045270579
R&D to revenue (%): 3.7338496128090704
SG&A to revenue (%): 4.301478127662627
Free cash flow (dilution-adjusted): 17683403.656821378
Retained earnings: 60038677.91842475
Inventory turnover: 8.22666147974472
Receivables turnover: 27.717011606116767
Capitalized R&D asset: 26862188.266889762
ROCI (R&D-adjusted, %): 16.602373327052923
Rosenberg metric: -2.8305807287956366
FCF margin (%): 4.6964573271928645
Revenue growth (%): -16.376478100472582
Rule of 40 score: -11.680020773279718
Financial ratios for APUS — annual report dated 2022-12-31
Total revenue: 0
Operating income: -639529
Net income: -668666
Capital expenditures: 0
Operating cash flow: -448167
Net tangible assets: -713606
Owner earnings: -668666
Buffett classification: The Gruesome
Shares outstanding: 1509117
Book value: -713606
Debt to equity: -0.9248801159183079
Current ratio: 0.019297823170521956
Quick ratio: 0.019297823170521956
Interest coverage ratio: -21.94903387445516
Free cash flow (dilution-adjusted): -641709
Retained earnings: -2224240
Capitalized R&D asset: 368000
ROCI (R&D-adjusted, %): -724.7043178781973
Rule of 40 score: 0
Financial ratios for APUS — annual report dated 2023-12-31
Total revenue: 0
Operating income: -747436
Net income: -777694
Capital expenditures: 0
Operating cash flow: -627790
Net tangible assets: 31869
Owner earnings: -777694
Return on net tangible assets (%): -2440.283661238194
Buffett classification: The Gruesome
Shares outstanding: 1509117
Book value: 31869
Debt to equity: 8.374627380840314
Current ratio: 3.422718868597749
Quick ratio: 3.422718868597749
Interest coverage ratio: -19.633717723081773
Free cash flow (dilution-adjusted): -697783
Retained earnings: -3001934
Capitalized R&D asset: 345104
ROCI (R&D-adjusted, %): -124.93425112549647
Rule of 40 score: 0
Financial ratios for APUS — annual report dated 2024-12-31
Total revenue: 0
Operating income: -1275095
Net income: -1389990
Capital expenditures: 0
Operating cash flow: -733526
Depreciation & amortization: 0
Net tangible assets: -1358121
Owner earnings: -1389990
Buffett classification: The Gruesome
Shares outstanding: 1509117
Book value: -1358121
Debt to equity: -0.43946305226117555
Current ratio: 0.012746818908676271
Quick ratio: 0.012746818908676271
Interest coverage ratio: -10.831683925279691
Free cash flow (dilution-adjusted): -733526
Retained earnings: -4391924
Capitalized R&D asset: 187464.48
Rule of 40 score: 0
Financial ratios for APUS — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -275613
Net income: -311633
Capital expenditures: 0
Operating cash flow: -99616
Net tangible assets: -1358121
Owner earnings: -311633
Buffett classification: The Gruesome
Shares outstanding: 1509117
Book value: -1358121
Debt to equity: -0.43946305226117555
Current ratio: 0.012746818908676271
Quick ratio: 0.012746818908676271
Interest coverage ratio: -7.645298196948683
Free cash flow (dilution-adjusted): -99616
Retained earnings: -4391924
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APUS — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -364368
Net income: -402397
Capital expenditures: 0
Operating cash flow: -20313
Depreciation & amortization: 0
Net tangible assets: -1760518
Owner earnings: -402397
Buffett classification: The Gruesome
Shares outstanding: 1509117
Book value: -1760518
Debt to equity: -0.49622895079743573
Current ratio: 0.14680341749029327
Quick ratio: 0.14680341749029327
Interest coverage ratio: -9.58056373580143
Free cash flow (dilution-adjusted): -20313
Retained earnings: -4794321
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVTNPL.NS — annual report dated 2022-03-31
Total revenue: 73062284.05644204
Gross profit: 34622735.0652776
Operating income: 12036384.016879864
Net income: 9607055.255176052
Capital expenditures: 1012514.835816959
Operating cash flow: 9806435.447711987
Depreciation & amortization: 1893393.116180931
Net tangible assets: 48432704.73427404
Owner earnings: 10487933.535540024
Return on net tangible assets (%): 21.654651733951376
Capex to operating income (%): 8.412118077962658
Buffett classification: The Great
Shares outstanding: 152284000
Book value: 48629355.13648952
Debt to equity: 0.0683198989902277
Current ratio: 5.389661282475865
Quick ratio: 2.662173642013054
Effective tax rate (%): 24.619789370864968
Interest coverage ratio: 35.68933291624306
COGS to revenue (%): 52.61202751541294
R&D to revenue (%): 0.0019854473925931624
SG&A to revenue (%): 4.9662356621367785
Free cash flow (dilution-adjusted): 8560807.068442568
Retained earnings: 13274548.331794804
Inventory turnover: 1.589968084682775
Receivables turnover: 5.425312647804488
Capitalized R&D asset: 1450.6132137676382
ROCI (R&D-adjusted, %): 23.92256689970923
FCF margin (%): 11.717135836910298
Rule of 40 score: 11.717135836910298
Financial ratios for AVTNPL.NS — annual report dated 2023-03-31
Total revenue: 70909342.26552984
Gross profit: 37926820.950060904
Operating income: 13097965.895249696
Net income: 9427369.062119367
Capital expenditures: 961412.9110840439
Operating cash flow: 6233288.672350792
Depreciation & amortization: 1630353.2277710112
Net tangible assets: 52212959.805115715
Owner earnings: 10096309.378806334
Return on net tangible assets (%): 19.336788062754334
Capex to operating income (%): 7.340169601699179
Buffett classification: The Great
Shares outstanding: 152284000
Book value: 52415249.6954933
Debt to equity: 0.08598208069543038
Current ratio: 5.624070996188244
Quick ratio: 2.9176910920310553
Effective tax rate (%): 25.954831630295544
Interest coverage ratio: 34.20846190551933
COGS to revenue (%): 46.513647231363855
R&D to revenue (%): 0
SG&A to revenue (%): 5.328500116032258
Free cash flow (dilution-adjusted): 5246638.246041413
Retained earnings: 17179951.27892814
Inventory turnover: 1.2772429986330742
Receivables turnover: 4.795603962908076
Capitalized R&D asset: 971.9108532243176
ROCI (R&D-adjusted, %): 24.151447528823116
Rosenberg metric: 2277.7166603919823
FCF margin (%): 7.399078990740953
Revenue growth (%): -2.94672116909048
Rule of 40 score: 4.452357821650473
Financial ratios for AVTNPL.NS — annual report dated 2024-03-31
Total revenue: 62028924.33145461
Gross profit: 31000407.72274853
Operating income: 7918995.083343326
Net income: 6390238.637726346
Capital expenditures: 1494183.9549106606
Operating cash flow: 11813934.524523323
Depreciation & amortization: 1664144.381820362
Net tangible assets: 56145592.9967622
Owner earnings: 6560199.064636048
Return on net tangible assets (%): 11.684263562795321
Capex to operating income (%): 18.868353107751016
Buffett classification: The Great
Shares outstanding: 152284000
Book value: 56303573.56997242
Debt to equity: 0.09072586528027296
Current ratio: 4.5250200724202285
Quick ratio: 2.5652331502445027
Effective tax rate (%): 25.02128150542204
Interest coverage ratio: 13.06489266989811
COGS to revenue (%): 50.02265788602697
SG&A to revenue (%): 4.931280100962921
Free cash flow (dilution-adjusted): 10319750.569612663
Retained earnings: 18662909.221729223
Inventory turnover: 1.17003180264903
Receivables turnover: 4.703634897122035
Capitalized R&D asset: 478.7023605433206
ROCI (R&D-adjusted, %): 13.607868751351928
FCF margin (%): 16.636997466647284
Revenue growth (%): -12.523621923922626
Rule of 40 score: 4.113375542724658
Financial ratios for AVTNPL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 56577890.587673195
Buffett classification: The Gruesome
Shares outstanding: 152284000
Book value: 56714739.608217865
Debt to equity: 0.20147686745049345
Current ratio: 2.74876927798798
Quick ratio: 1.4157460455631585
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVTNPL.NS — quarterly report dated 2024-12-31
Total revenue: 20150227.299219023
Gross profit: 11191992.073668258
Operating income: 3091409.255157944
Net income: 2518009.091968761
Capital expenditures: 0
Depreciation & amortization: 393484.0890546683
Owner earnings: 2911493.181023429
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 152284000
Effective tax rate (%): 22.55182452441901
Interest coverage ratio: 9.4331139960875
COGS to revenue (%): 44.45724156123025
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVTNPL.NS — quarterly report dated 2025-03-31
Total revenue: 18333493.102642037
Gross profit: 9840881.458966564
Operating income: 2451402.852466682
Net income: 1678431.1433247603
Capital expenditures: 0
Depreciation & amortization: 420914.19219078793
Net tangible assets: 59085106.38297872
Owner earnings: 2099345.335515548
Return on net tangible assets (%): 3.5530871721004957
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 152284000
Book value: 59198971.24152443
Debt to equity: 0.22257972147839206
Current ratio: 2.9029373016335174
Quick ratio: 1.6168162674854758
Effective tax rate (%): 27.12474367043632
Interest coverage ratio: 6.2225288584230976
COGS to revenue (%): 46.32293254825292
Retained earnings: 20069487.95884966
Inventory turnover: 0.24730838704757652
Receivables turnover: 1.0029200329223158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.043130478508993
Revenue growth (%): -9.015948900226048
Rule of 40 score: -9.015948900226048
Financial ratios for AVTNPL.NS — annual report dated 2025-03-31
Total revenue: 65333715.22094926
Gross profit: 36281447.27612813
Operating income: 6929693.710544774
Net income: 5637947.159223755
Capital expenditures: 1078454.524199205
Operating cash flow: -3798830.9562777644
Depreciation & amortization: 1620645.3121346738
Net tangible assets: 59085106.38297872
Owner earnings: 6180137.947159223
Return on net tangible assets (%): 10.459722128789467
Capex to operating income (%): 15.56280218501061
Buffett classification: The Great
Shares outstanding: 152284000
Book value: 59198971.24152443
Debt to equity: 0.22257972147839206
Current ratio: 2.9029373016335174
Quick ratio: 1.6168162674854758
Effective tax rate (%): 23.610352130188854
Interest coverage ratio: 6.246217070600633
COGS to revenue (%): 44.46749713615784
SG&A to revenue (%): 5.967116185208367
Free cash flow (dilution-adjusted): -4880173.018470891
Retained earnings: 20069487.95884966
Inventory turnover: 0.8460141387553457
Receivables turnover: 3.57403204362015
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.429233599709395
FCF margin (%): -7.469608917795116
Revenue growth (%): 5.327822342743422
Rule of 40 score: -2.141786575051694
Financial ratios for AVTNPL.NS — quarterly report dated 2025-06-30
Total revenue: 15494968.406271942
Gross profit: 8584846.711912006
Operating income: 1515293.7046571497
Net income: 1417680.7863327875
Capital expenditures: 0
Depreciation & amortization: 344652.468991341
Owner earnings: 1762333.2553241285
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 152284000
Effective tax rate (%): 18.419635041411354
Interest coverage ratio: 6.60362060173381
COGS to revenue (%): 44.59590696269446
Capitalized R&D asset: 0
Revenue growth (%): -15.482727053040621
Rule of 40 score: -15.482727053040621
Financial ratios for AVTNPL.NS — quarterly report dated 2025-09-30
Total revenue: 18072841.037204057
Gross profit: 10049864.712514091
Operating income: 1378004.5095828637
Net income: 1498827.5084554679
Capital expenditures: 0
Depreciation & amortization: 297621.19503945886
Net tangible assets: 58911082.299887255
Owner earnings: 1796448.7034949267
Return on net tangible assets (%): 3.0494240359565836
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 152284000
Book value: 59001533.258173615
Debt to equity: 0.19139490766677955
Current ratio: 2.6779650536546784
Quick ratio: 1.347566435691106
Effective tax rate (%): 15.606987786608437
Interest coverage ratio: 6.75933196925289
COGS to revenue (%): 44.39244670040628
Inventory turnover: 0.20417017404032806
Receivables turnover: 1.118322064498846
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.304839429274623
Revenue growth (%): 16.63683696114322
Rule of 40 score: 16.63683696114322
Financial ratios for AVTNPL.NS — quarterly report dated 2025-12-31
Total revenue: 21612309.234710928
Gross profit: 10458326.835245628
Operating income: 2277943.6337306453
Net income: 1935479.5588726746
Capital expenditures: 0
Depreciation & amortization: 295388.2143254985
Owner earnings: 2230867.773198173
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 152284000
Effective tax rate (%): 19.7261185341243
Interest coverage ratio: 9.158090375744548
COGS to revenue (%): 51.609396656009345
Capitalized R&D asset: 0
Revenue growth (%): 19.58445930122806
Rule of 40 score: 19.58445930122806
Financial ratios for BAFNAPH.NS — annual report dated 2022-03-31
Total revenue: 11227785.836740077
Gross profit: 4465224.845048134
Operating income: 871475.6692601873
Net income: 687893.9733614664
Capital expenditures: 994487.669787683
Operating cash flow: 1282909.1388632467
Depreciation & amortization: 724423.0515627061
Net tangible assets: 8171396.5449030725
Owner earnings: 417829.3551364896
Return on net tangible assets (%): 5.113316344892253
Capex to operating income (%): 114.115368319109
Buffett classification: The Gruesome
Shares outstanding: 23656335
Book value: 8171396.544903073
Debt to equity: 0.17848191763887564
Current ratio: 2.3113838829403024
Quick ratio: 1.3900748204445617
Effective tax rate (%): 0
Interest coverage ratio: 12.606638687523848
COGS to revenue (%): 60.23058410646897
R&D to revenue (%): 1.7245652176466373
SG&A to revenue (%): 3.0266513037891576
Free cash flow (dilution-adjusted): 288421.4690755638
Retained earnings: -8700250.560464196
Inventory turnover: 2.528561919084835
Receivables turnover: 5.760663346775285
Capitalized R&D asset: 193630.48925227483
ROCI (R&D-adjusted, %): 10.901213885400713
FCF margin (%): 2.5688187615030724
Rule of 40 score: 2.5688187615030724
Financial ratios for BAFNAPH.NS — annual report dated 2023-03-31
Total revenue: 14049926.918392206
Gross profit: 4720572.472594397
Operating income: 1469963.4591961023
Net income: 1380998.7819732034
Capital expenditures: 794433.6175395859
Operating cash flow: 603227.7710109623
Depreciation & amortization: 649744.2143727163
Net tangible assets: 8764263.093788063
Owner earnings: 1236309.3788063335
Return on net tangible assets (%): 14.106255889130088
Capex to operating income (%): 54.0444466540718
Buffett classification: The Good
Shares outstanding: 23656335
Book value: 8946967.113276493
Debt to equity: 0.3120825652852238
Current ratio: 1.8786284622485008
Quick ratio: 1.4005439331444198
Effective tax rate (%): 2.3957714590704446
Interest coverage ratio: 6.713991655076494
COGS to revenue (%): 66.40144464797976
R&D to revenue (%): 0.6252281102974515
SG&A to revenue (%): 1.7709594893450273
Free cash flow (dilution-adjusted): -397831.91230207065
Retained earnings: -6636187.576126675
Inventory turnover: 3.4471367621379323
Receivables turnover: 2.8032589280289684
Capitalized R&D asset: 217576.5203690607
ROCI (R&D-adjusted, %): 14.158139211137433
Rosenberg metric: 1.3187366748507197
FCF margin (%): -2.8315585882605876
Revenue growth (%): 25.13533053344667
Rule of 40 score: 22.30377194518608
Financial ratios for BAFNAPH.NS — annual report dated 2024-03-31
Total revenue: 18283451.25314786
Gross profit: 5463304.95263221
Operating income: 782695.7668785226
Net income: 881148.8188032138
Capital expenditures: 1847595.6349682217
Operating cash flow: 1137402.5662549466
Depreciation & amortization: 599040.6523563976
Net tangible assets: 9481796.378462646
Owner earnings: -367406.1638086103
Return on net tangible assets (%): -3.874858192938547
Capex to operating income (%): 236.05540149228577
Buffett classification: The Gruesome
Shares outstanding: 23656335
Book value: 9694052.044609664
Debt to equity: 0.30170326836032746
Current ratio: 1.7338276353012965
Quick ratio: 1.185747832035945
Effective tax rate (%): 0
Interest coverage ratio: 3.3687225806451613
COGS to revenue (%): 70.11885296168253
R&D to revenue (%): 0.17479341255115086
SG&A to revenue (%): 6.166501711532496
Free cash flow (dilution-adjusted): -763089.0994123996
Retained earnings: -5648039.333253387
Inventory turnover: 3.606636574027218
Receivables turnover: 3.3586600227338814
Capitalized R&D asset: 154711.87185267848
ROCI (R&D-adjusted, %): 6.24116308273587
Rosenberg metric: 8.455121548960683
FCF margin (%): -4.173660042881776
Revenue growth (%): 30.13200253172644
Rule of 40 score: 25.958342488844664
Financial ratios for BAFNAPH.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 9672826.086956521
Buffett classification: The Gruesome
Shares outstanding: 23656335
Book value: 9884245.102723364
Debt to equity: 0.22746822088944046
Current ratio: 1.9634036909457884
Quick ratio: 1.2404983013649604
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BAFNAPH.NS — quarterly report dated 2024-12-31
Total revenue: 3868469.51859191
Gross profit: 1114547.1500174846
Operating income: 163830.283249796
Net income: 110467.42044527334
Capital expenditures: 0
Depreciation & amortization: 192994.52150600302
Owner earnings: 303461.9419512764
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 23656335
Effective tax rate (%): 0
Interest coverage ratio: 2.2119924457034936
COGS to revenue (%): 71.1889380370982
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BAFNAPH.NS — annual report dated 2025-03-31
Total revenue: 17051321.019406125
Gross profit: 5003039.513677811
Operating income: 735001.1690437222
Net income: 485445.40565817157
Capital expenditures: 2548643.909282207
Operating cash flow: 2587783.493102642
Depreciation & amortization: 571627.3088613513
Net tangible assets: 9914250.642974047
Owner earnings: -1491571.1947626842
Return on net tangible assets (%): -15.044719449570493
Capex to operating income (%): 346.75372184756327
Buffett classification: The Gruesome
Shares outstanding: 23656335
Book value: 9914250.642974049
Debt to equity: 0.3325051735421223
Current ratio: 1.6340370711085654
Quick ratio: 1.0923749848124555
Effective tax rate (%): 0
Interest coverage ratio: 2.3019075165672027
COGS to revenue (%): 70.65893306457694
R&D to revenue (%): 0.9969353544910426
SG&A to revenue (%): 2.1124114715097666
Free cash flow (dilution-adjusted): 32288.987608136544
Retained earnings: -5042225.859247136
Inventory turnover: 3.6694663908481417
Receivables turnover: 3.6306769387780506
Capitalized R&D asset: 220391.2380112614
ROCI (R&D-adjusted, %): 6.706262617374331
Rosenberg metric: -14.402076905968979
FCF margin (%): 0.1893635547145492
Revenue growth (%): -6.739046237397868
Rule of 40 score: -6.5496826826833185
Financial ratios for BAFNAPH.NS — quarterly report dated 2025-03-31
Total revenue: 4566284.779050736
Gross profit: 1458615.8522328734
Operating income: 338660.2758943184
Net income: 153261.63198503622
Capital expenditures: 0
Depreciation & amortization: 25146.1304652794
Net tangible assets: 9914250.642974047
Owner earnings: 178407.7624503156
Return on net tangible assets (%): 1.7995082924068317
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 23656335
Book value: 9914250.642974049
Debt to equity: 0.3325051735421223
Current ratio: 1.6340370711085654
Quick ratio: 1.0923749848124555
Effective tax rate (%): 0
Interest coverage ratio: 3.523351982486013
COGS to revenue (%): 68.0568356374808
Retained earnings: -5042225.859247136
Inventory turnover: 0.9464824236900103
Receivables turnover: 0.9722827236860119
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.861774578819568
Revenue growth (%): 18.038535837108636
Rule of 40 score: 18.038535837108636
Financial ratios for BAFNAPH.NS — quarterly report dated 2025-06-30
Total revenue: 4051486.0753568923
Gross profit: 1428293.938684765
Operating income: 432798.9702784929
Net income: 396548.09267493564
Capital expenditures: 0
Depreciation & amortization: 160297.21507137842
Owner earnings: 556845.3077463141
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 23656335
Effective tax rate (%): 0
Interest coverage ratio: 4.085155732273029
COGS to revenue (%): 64.74641866913124
Capitalized R&D asset: 0
Revenue growth (%): -11.273907095230767
Rule of 40 score: -11.273907095230767
Financial ratios for BAFNAPH.NS — quarterly report dated 2025-09-30
Total revenue: 3998669.6730552423
Gross profit: 1398726.0428410373
Operating income: 316753.10033821873
Net income: 352299.8872604284
Capital expenditures: 0
Depreciation & amortization: 166031.5670800451
Net tangible assets: 10284994.36302142
Owner earnings: 518331.4543404735
Return on net tangible assets (%): 5.039686324030258
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 23656335
Book value: 10284994.363021418
Debt to equity: 0.3551852010185481
Current ratio: 1.674452747087278
Quick ratio: 1.0261648273280337
Effective tax rate (%): 0
Interest coverage ratio: 3.25072312854333
COGS to revenue (%): 65.02021529144416
Inventory turnover: 0.7439529527139935
Receivables turnover: 1.0891141401641584
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.48931038943319
Revenue growth (%): -1.3036303548691692
Rule of 40 score: -1.3036303548691692
Financial ratios for BAFNAPH.NS — quarterly report dated 2025-12-31
Total revenue: 4264876.907652891
Gross profit: 1227381.0849949874
Operating income: 164854.62849504288
Net income: 204622.92525342543
Capital expenditures: 0
Depreciation & amortization: 174891.3891054918
Owner earnings: 379514.31435891724
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 23656335
Effective tax rate (%): 0
Interest coverage ratio: 1.7160250463821891
COGS to revenue (%): 71.22118383317051
Capitalized R&D asset: 0
Revenue growth (%): 6.65739499292647
Rule of 40 score: 6.65739499292647
Financial ratios for BIOV.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 11868888.888888888
Buffett classification: The Gruesome
Shares outstanding: 5848011
Book value: 11868888.888888888
Debt to equity: 1.5881857330088
Current ratio: 3.5560839450015505
Quick ratio: 3.5560839450015505
Retained earnings: -89267777.77777778
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOV.SW — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -4387777.777777778
Operating income: -20802222.22222222
Net income: -20798888.888888888
Capital expenditures: 42222.22222222222
Operating cash flow: -17304444.444444444
Depreciation & amortization: 313333.3333333333
Net tangible assets: 11868888.888888888
Owner earnings: -20527777.77777778
Return on net tangible assets (%): -172.9545029020783
Buffett classification: The Gruesome
Shares outstanding: 5848011
Book value: 11868888.888888888
Debt to equity: 1.5881857330088
Current ratio: 3.5560839450015505
Quick ratio: 3.5560839450015505
Interest coverage ratio: -18.054001928640307
Free cash flow (dilution-adjusted): -19408888.88888889
Retained earnings: -89267777.77777778
Capitalized R&D asset: 14385555.555555556
ROCI (R&D-adjusted, %): -26.394628999912804
Rule of 40 score: 0
Financial ratios for DEVS — annual report dated 2022-07-31
Total revenue: 0
Net income: -75617.1875
Capital expenditures: 0
Operating cash flow: -42804.03125
Net tangible assets: 612399.21875
Owner earnings: -75617.1875
Return on net tangible assets (%): -12.347694965115434
Buffett classification: The Gruesome
Shares outstanding: 35067694
Book value: 612399.21875
Debt to equity: 0
Current ratio: 1.2275487406030465
Quick ratio: 1.2275487406030465
Free cash flow (dilution-adjusted): -42804.03125
Retained earnings: -4648303.125
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEVS — annual report dated 2023-07-31
Total revenue: 0
Operating income: -4489139.84962406
Net income: -4439588.721804511
Capital expenditures: 0
Operating cash flow: -2562514.2857142854
Depreciation & amortization: 1390.2255639097743
Net tangible assets: -41174.436090225565
Owner earnings: -4438198.496240601
Buffett classification: The Gruesome
Shares outstanding: 35067694
Book value: -41174.43609022547
Debt to equity: 0
Current ratio: 0.9366281040486347
Quick ratio: 0.9366281040486347
Free cash flow (dilution-adjusted): -3945078.9473684207
Retained earnings: -8913143.609022556
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEVS — annual report dated 2024-07-31
Total revenue: 0
Gross profit: 0
Operating income: -6330810.144927537
Net income: -7153440.5797101455
Capital expenditures: 0
Operating cash flow: -1122425.3623188406
Depreciation & amortization: 1283.3333333333335
Net tangible assets: -6058992.7536231885
Owner earnings: -7152157.246376812
Buffett classification: The Gruesome
Shares outstanding: 35067694
Book value: -6058992.753623189
Debt to equity: -0.12067868935980892
Current ratio: 0.016686327382909382
Quick ratio: 0.016686327382909382
Interest coverage ratio: -106.73815516188151
Free cash flow (dilution-adjusted): -2057444.927536232
Retained earnings: -15743644.202898553
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EIEL.NS — annual report dated 2022-03-31
Total revenue: 29477133.06079388
Gross profit: 8913807.200316498
Operating income: 6371528.418831597
Net income: 4556283.792694184
Capital expenditures: 529539.7599894501
Operating cash flow: 5485467.493076619
Depreciation & amortization: 226625.3461690624
Net tangible assets: 9441078.72873533
Owner earnings: 4253369.378873796
Return on net tangible assets (%): 45.05173085706862
Capex to operating income (%): 8.311031909146791
Buffett classification: The Great
Shares outstanding: 175530000
Book value: 9446630.621126205
Debt to equity: 0.25284013971058356
Current ratio: 1.672016096579477
Quick ratio: 1.549601609657948
Effective tax rate (%): 25.00765148308534
Interest coverage ratio: 19.280617742128577
COGS to revenue (%): 69.76026405983042
SG&A to revenue (%): 0.9169440031566926
Free cash flow (dilution-adjusted): 4955927.733087169
Retained earnings: 8627100.09231175
Inventory turnover: 18.639854162931083
Receivables turnover: 3.827733653902137
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 60.44762114471306
FCF margin (%): 16.812787467716156
Rule of 40 score: 16.812787467716156
Financial ratios for EIEL.NS — annual report dated 2023-03-31
Total revenue: 41181729.59805116
Gross profit: 13540657.734470159
Operating income: 9690706.455542022
Net income: 6740426.3093788065
Capital expenditures: 1310328.8672350792
Operating cash flow: 12312813.641900122
Depreciation & amortization: 280645.55420219246
Net tangible assets: 15406638.246041413
Owner earnings: 5710742.99634592
Return on net tangible assets (%): 37.06676891575123
Capex to operating income (%): 13.521499936526451
Buffett classification: The Great
Shares outstanding: 175530000
Book value: 15455079.17174178
Debt to equity: 0.5086778546445555
Current ratio: 1.450108807103447
Quick ratio: 1.3887955206546274
Effective tax rate (%): 25.807896091638423
Interest coverage ratio: 14.053929448340428
COGS to revenue (%): 67.11974492904508
SG&A to revenue (%): 1.8571614483203294
Free cash flow (dilution-adjusted): 11002484.774665043
Retained earnings: 12315602.923264313
Inventory turnover: 23.09823200708419
Receivables turnover: 4.157422880323247
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 42.46698109179106
FCF margin (%): 26.71690791536282
Revenue growth (%): 39.70737762426768
Rule of 40 score: 66.4242855396305
Financial ratios for EIEL.NS — annual report dated 2024-03-31
Total revenue: 87410360.9545509
Gross profit: 25563484.830315385
Operating income: 19369624.65523444
Net income: 13002878.042930806
Capital expenditures: 3976639.884878283
Operating cash flow: -12252116.560738698
Depreciation & amortization: 729631.8503417675
Net tangible assets: 35038218.01175201
Owner earnings: 9755870.00839429
Return on net tangible assets (%): 27.843510777637487
Capex to operating income (%): 20.53028881901249
Buffett classification: The Great
Shares outstanding: 175530000
Book value: 34847607.62681377
Debt to equity: 0.8064772111762726
Current ratio: 1.5372359895842465
Quick ratio: 1.4405949166213678
Effective tax rate (%): 27.57402890741667
Interest coverage ratio: 9.443763630091736
COGS to revenue (%): 70.7546284546209
SG&A to revenue (%): 0.41257211060274523
Free cash flow (dilution-adjusted): -16258460.247032018
Retained earnings: 18648195.227245472
Inventory turnover: 14.621578789201815
Receivables turnover: 5.138827984992027
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 40.7674842039322
FCF margin (%): -18.60015228113017
Revenue growth (%): 112.25519619430318
Rule of 40 score: 93.65504391317302
Financial ratios for HMH — annual report dated 2022-12-31
Total revenue: 677213000
Gross profit: 221504000
Operating income: 20317000
Net income: -26564000
Capital expenditures: 6478000
Operating cash flow: 974000
Depreciation & amortization: 41600000
Net tangible assets: 124139000
Owner earnings: 8558000
Capex to operating income (%): 31.884628636117533
Buffett classification: The Good
Shares outstanding: 12110772
Book value: 567243000
Debt to equity: 0.6042807050946419
Current ratio: 1.426666059966917
Quick ratio: 0.9337564171881608
Interest coverage ratio: 0.6208403361344538
COGS to revenue (%): 67.2918269436647
R&D to revenue (%): 0.4248294111306191
SG&A to revenue (%): 20.94038360161426
Free cash flow (dilution-adjusted): -14017000
Retained earnings: -30131000
Inventory turnover: 2.4746082083473615
Receivables turnover: 2.4400554874972977
Capitalized R&D asset: 2877000
ROCI (R&D-adjusted, %): 2.4074457038977126
FCF margin (%): -2.0698066930197734
Rule of 40 score: -2.0698066930197734
Financial ratios for HMH — annual report dated 2023-12-31
Total revenue: 785446000
Gross profit: 210388000
Operating income: 78001000
Net income: 17402000
Capital expenditures: 13515000
Operating cash flow: 25574000
Depreciation & amortization: 38831000
Net tangible assets: 158039000
Owner earnings: 42718000
Return on net tangible assets (%): 27.030036889628512
Capex to operating income (%): 17.326700939731545
Buffett classification: The Great
Shares outstanding: 12110772
Book value: 593131000
Debt to equity: 0.629194899609024
Current ratio: 1.6715830483160727
Quick ratio: 1.0278612676823646
Effective tax rate (%): 46.878720351659084
Interest coverage ratio: 1.68581555685232
COGS to revenue (%): 73.21419932115002
R&D to revenue (%): 0.38716856410243355
SG&A to revenue (%): 16.222248251311992
Free cash flow (dilution-adjusted): 917000
Retained earnings: -12729000
Inventory turnover: 2.37403603216804
Receivables turnover: 2.643264344607101
Capitalized R&D asset: 4968590
ROCI (R&D-adjusted, %): 7.929981109730464
Rosenberg metric: -3.8637469586374698
FCF margin (%): 0.11674895537057926
Revenue growth (%): 15.982120839381405
Rule of 40 score: 16.098869794751984
Financial ratios for HMH — annual report dated 2024-12-31
Total revenue: 843363000
Gross profit: 272190000
Operating income: 118313000
Net income: 51956000
Capital expenditures: 15883000
Operating cash flow: 34861000
Depreciation & amortization: 39402000
Net tangible assets: 194074000
Owner earnings: 75475000
Return on net tangible assets (%): 38.88980491977287
Capex to operating income (%): 13.424560276554562
Buffett classification: The Great
Shares outstanding: 12110772
Book value: 631337000
Debt to equity: 0.5992203846756962
Current ratio: 1.9387636406362447
Quick ratio: 1.1164128247683112
Effective tax rate (%): 32.07389297807528
Interest coverage ratio: 3.1757616427325193
COGS to revenue (%): 67.72564127190782
R&D to revenue (%): 0.8379547122650627
SG&A to revenue (%): 17.407688029946772
Free cash flow (dilution-adjusted): 16329000
Retained earnings: 38489000
Inventory turnover: 2.0402168904510334
Receivables turnover: 2.7453133290581735
Capitalized R&D asset: 10053880
ROCI (R&D-adjusted, %): 11.519559711519051
Rosenberg metric: 20.322920092074977
FCF margin (%): 1.9361769487160334
Revenue growth (%): 7.373772353541809
Rule of 40 score: 9.309949302257841
Financial ratios for HMH — quarterly report dated 2025-03-31
Total revenue: 198430000
Gross profit: 56547000
Operating income: 19278000
Net income: 6112000
Capital expenditures: 2303000
Operating cash flow: 13587000
Depreciation & amortization: 10311000
Net tangible assets: 216327000
Owner earnings: 14120000
Return on net tangible assets (%): 6.527155648624536
Capex to operating income (%): 11.94625998547567
Buffett classification: The Great
Shares outstanding: 12110772
Book value: 650794000
Debt to equity: 0.5839236378946333
Current ratio: 2.080847124396343
Quick ratio: 1.186031418809292
Effective tax rate (%): 47.20675408658164
Interest coverage ratio: 2.1002287830918402
COGS to revenue (%): 71.50279695610543
R&D to revenue (%): 0.5195786927379933
SG&A to revenue (%): 18.26235952224966
Free cash flow (dilution-adjusted): 11180000
Retained earnings: 44601000
Inventory turnover: 0.5044352243921343
Receivables turnover: 0.659575528926856
Capitalized R&D asset: 1031000
ROCI (R&D-adjusted, %): 1.856497710993122
FCF margin (%): 5.634228695257773
Rule of 40 score: 5.634228695257773
Financial ratios for HMH — quarterly report dated 2025-06-30
Total revenue: 203457000
Gross profit: 51912000
Operating income: 21822000
Net income: 9768000
Capital expenditures: 2537000
Operating cash flow: -21139000
Depreciation & amortization: 10682000
Net tangible assets: 237754000
Owner earnings: 17913000
Return on net tangible assets (%): 7.534258098707067
Capex to operating income (%): 11.62588213729264
Buffett classification: The Great
Shares outstanding: 12110772
Book value: 669347000
Debt to equity: 0.5922772493191125
Current ratio: 2.223805487337043
Quick ratio: 1.2652838318217303
Effective tax rate (%): 34.55714859975881
Interest coverage ratio: 2.3964419064353173
COGS to revenue (%): 74.4850263200578
R&D to revenue (%): 0.3189863214340131
SG&A to revenue (%): 14.470379490506593
Free cash flow (dilution-adjusted): -24645000
Retained earnings: 53550000
Inventory turnover: 0.5297127816868178
Receivables turnover: 0.6635109266005081
Capitalized R&D asset: 1339770
ROCI (R&D-adjusted, %): 1.9940050258463948
Rosenberg metric: -4.495635305528613
FCF margin (%): -12.113124640587445
Revenue growth (%): 2.53338708864587
Rule of 40 score: -9.579737551941575
Financial ratios for HMH — quarterly report dated 2025-09-30
Total revenue: 217171000
Gross profit: 59766000
Operating income: 28307000
Net income: 16186000
Capital expenditures: 1746000
Operating cash flow: 36500000
Depreciation & amortization: 10884000
Net tangible assets: 257543000
Owner earnings: 25324000
Return on net tangible assets (%): 9.83292110443693
Capex to operating income (%): 6.168085632529056
Buffett classification: The Great
Shares outstanding: 12110772
Book value: 686342000
Debt to equity: 0.5630982804491056
Current ratio: 2.6730591021416803
Quick ratio: 1.5761128844041736
Effective tax rate (%): 21.52984334721396
Interest coverage ratio: 3.396568274538037
COGS to revenue (%): 72.47975097964276
R&D to revenue (%): 0.045125730415202764
SG&A to revenue (%): 14.440694199501774
Free cash flow (dilution-adjusted): 31428000
Retained earnings: 69736000
Inventory turnover: 0.6156207833858067
Receivables turnover: 0.7913818234822535
Capitalized R&D asset: 873060
ROCI (R&D-adjusted, %): 2.487837528635983
Rosenberg metric: 12.101694915254237
FCF margin (%): 14.471545464173394
Revenue growth (%): 6.74049061963953
Rule of 40 score: 21.212036083812926
Financial ratios for HMH — annual report dated 2025-12-31
Total revenue: 821754000
Gross profit: 245730000
Operating income: 91334000
Net income: 35155000
Capital expenditures: 9279000
Operating cash flow: 88310000
Depreciation & amortization: 42460000
Net tangible assets: -214572000
Owner earnings: 68336000
Return on net tangible assets (%): -31.847584959827003
Capex to operating income (%): 10.15941489478179
Buffett classification: The Great
Shares outstanding: 12110772
Book value: 829998000
Debt to equity: 0.2972814392323837
Current ratio: 2.807202679318008
Quick ratio: 1.672521340195583
Effective tax rate (%): 42.9505696017656
Interest coverage ratio: 2.7565038932818253
COGS to revenue (%): 70.09689031023883
R&D to revenue (%): 0.34231655702314806
SG&A to revenue (%): 18.446274675876236
Free cash flow (dilution-adjusted): 71329000
Retained earnings: 62757000
Inventory turnover: 2.2699648091299225
Receivables turnover: 3.3406806946793286
Capitalized R&D asset: 8551420
ROCI (R&D-adjusted, %): 7.937416545141909
Rosenberg metric: -3.744163011178718
FCF margin (%): 8.680091608924325
Revenue growth (%): -2.5622418816096983
Rule of 40 score: 6.117849727314627
Financial ratios for HMH — quarterly report dated 2025-12-31
Total revenue: 202696000
Gross profit: 77505000
Operating income: 21927000
Net income: 3680000
Capital expenditures: 2693000
Operating cash flow: 59362000
Depreciation & amortization: 10583000
Net tangible assets: -214572000
Owner earnings: 11570000
Return on net tangible assets (%): -5.392129448390284
Capex to operating income (%): 12.281661878049894
Buffett classification: The Great
Shares outstanding: 12110772
Book value: 829998000
Debt to equity: 0.2972814392323837
Current ratio: 2.807202679318008
Quick ratio: 1.672521340195583
Effective tax rate (%): 76.08836907082521
Interest coverage ratio: 3.365617805065234
COGS to revenue (%): 61.76293562773809
R&D to revenue (%): 0.5106168843983108
SG&A to revenue (%): 26.908769783320835
Free cash flow (dilution-adjusted): 53366000
Retained earnings: 62757000
Inventory turnover: 0.4933460488100915
Receivables turnover: 0.8240210745414336
Capitalized R&D asset: 1314830
ROCI (R&D-adjusted, %): 1.9889423236336203
Rosenberg metric: 181.01020408163265
FCF margin (%): 26.328097249082372
Revenue growth (%): -6.665254568980204
Rule of 40 score: 19.662842680102166
Financial ratios for LLOYDSME.NS — annual report dated 2023-03-31
Total revenue: 407190012.180268
Gross profit: 286665042.6309379
Operating income: 102548112.05846529
Net income: -35144945.18879416
Capital expenditures: 47302070.64555421
Operating cash flow: -62903775.88306943
Depreciation & amortization: 2802679.658952497
Net tangible assets: 186228989.03775886
Owner earnings: -79644336.17539588
Return on net tangible assets (%): -42.766884246602224
Capex to operating income (%): 46.12671037628279
Buffett classification: The Good
Shares outstanding: 562678119
Book value: 186228989.03775886
Debt to equity: 0.04301673054534514
Current ratio: 1.9520452235772359
Quick ratio: 1.3809281842818428
Interest coverage ratio: 13.171464330413015
COGS to revenue (%): 29.599195939013413
SG&A to revenue (%): 25.060199878553284
Free cash flow (dilution-adjusted): -111031668.69671133
Retained earnings: -14350791.717417784
Inventory turnover: 3.6682483781278963
Receivables turnover: 136.45020408163265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 54.187718428793005
FCF margin (%): -27.26777803369997
Rule of 40 score: -27.26777803369997
Financial ratios for MAMATA.NS — annual report dated 2022-03-31
Total revenue: 24964262.165369906
Gross profit: 13489647.896610841
Operating income: 3634181.7222735067
Net income: 2861268.627192404
Capital expenditures: 139918.2381643149
Operating cash flow: 4904655.149676909
Depreciation & amortization: 473954.8991164447
Net tangible assets: 13719504.15402875
Owner earnings: 3195305.288144534
Return on net tangible assets (%): 23.29023886192147
Capex to operating income (%): 3.8500616880760576
Buffett classification: The Great
Shares outstanding: 24607800
Book value: 13722273.50652776
Debt to equity: 0.2190839547935727
Current ratio: 0.9913734840235797
Quick ratio: 0.31732249464949497
Effective tax rate (%): 26.54297999119748
Interest coverage ratio: 36.21287779237845
COGS to revenue (%): 45.96416346194481
SG&A to revenue (%): 10.176224485483667
Free cash flow (dilution-adjusted): 4704074.904391402
Retained earnings: 12921007.516813926
Inventory turnover: 1.2117312834224598
Receivables turnover: 11.594536657071108
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.099046422033393
FCF margin (%): 18.84323627604277
Rule of 40 score: 18.84323627604277
Financial ratios for MAMATA.NS — annual report dated 2023-03-31
Total revenue: 24148842.874543242
Gross profit: 12793666.260657735
Operating income: 3424969.5493300855
Net income: 2741169.305724726
Capital expenditures: 93544.45797807553
Operating cash flow: 2091352.0097442146
Depreciation & amortization: 417295.9805115713
Net tangible assets: 15562119.366626067
Owner earnings: 3064920.828258222
Return on net tangible assets (%): 19.694752083904042
Capex to operating income (%): 2.731249333191081
Buffett classification: The Great
Shares outstanding: 24607800
Book value: 15575395.858708892
Debt to equity: 0.155723602921626
Current ratio: 1.0313130053418138
Quick ratio: 0.3009083161854878
Effective tax rate (%): 21.09396914446003
Interest coverage ratio: 43.66304347826087
COGS to revenue (%): 47.02161785919642
SG&A to revenue (%): 10.84070573281819
Free cash flow (dilution-adjusted): 1964190.012180268
Retained earnings: 15163824.604141291
Inventory turnover: 1.3264751497559797
Receivables turnover: 11.268087524865019
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.26264688535003
FCF margin (%): 8.133681693920165
Revenue growth (%): -3.2663464492766074
Rule of 40 score: 4.867335244643558
Financial ratios for MAMATA.NS — annual report dated 2024-03-31
Total revenue: 28078666.506775394
Gross profit: 15747331.81436623
Operating income: 5216332.89363233
Net income: 4271975.056961266
Capital expenditures: 143782.22808490228
Operating cash flow: 4823839.788943518
Depreciation & amortization: 409281.68845185277
Net tangible assets: 15797097.973378103
Owner earnings: 4537474.517328217
Return on net tangible assets (%): 28.723468861020855
Capex to operating income (%): 2.7563852042575694
Buffett classification: The Great
Shares outstanding: 24607800
Book value: 15815085.741695648
Debt to equity: 0.10214434115345536
Current ratio: 1.1998815048879234
Quick ratio: 0.5155623580527303
Effective tax rate (%): 23.277050310130946
Interest coverage ratio: 40.017479300827965
COGS to revenue (%): 43.91709517057587
SG&A to revenue (%): 8.389138493602337
Free cash flow (dilution-adjusted): 4666986.449214534
Retained earnings: 15781988.247991366
Inventory turnover: 1.4838314021442691
Receivables turnover: 6.280625519701726
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.850832167883368
FCF margin (%): 16.62111143379401
Revenue growth (%): 16.273341346615066
Rule of 40 score: 32.894452780409075
Financial ratios for NCEW — annual report dated 2022-09-30
Total revenue: 9577850.828025479
Gross profit: 1470529.9363057325
Operating income: 1073046.8789808918
Net income: 889385.9872611465
Capital expenditures: 58896.17834394905
Operating cash flow: 866373.6305732485
Depreciation & amortization: 30851.464968152868
Net tangible assets: 1468471.847133758
Owner earnings: 861341.2738853503
Return on net tangible assets (%): 58.655620505531815
Capex to operating income (%): 5.488686421592755
Buffett classification: The Great
Shares outstanding: 3200000
Book value: 1468471.847133758
Debt to equity: 0.3706875313164064
Current ratio: 2.04089449993988
Quick ratio: 2.04089449993988
Effective tax rate (%): 16.157105392538913
Interest coverage ratio: 102.86636462442146
COGS to revenue (%): 84.64655628167796
SG&A to revenue (%): 4.102691601531979
Free cash flow (dilution-adjusted): 807477.4522292993
Retained earnings: 1448898.98089172
Receivables turnover: 4.571747879719202
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 63.98252178131018
FCF margin (%): 8.430674759170005
Rule of 40 score: 8.430674759170005
Financial ratios for NCEW — annual report dated 2023-09-30
Total revenue: 4607152.490421456
Gross profit: 444953.0012771392
Operating income: 48144.18901660281
Net income: 58035.12132822478
Capital expenditures: 0
Operating cash flow: -317636.7816091954
Depreciation & amortization: 29166.155810983397
Net tangible assets: 764792.975734355
Owner earnings: 87201.27713920818
Return on net tangible assets (%): 11.401945350698
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 3200000
Book value: 764792.9757343552
Debt to equity: 0.8047831039343362
Current ratio: 1.4802153487485772
Quick ratio: 1.4802153487485772
Effective tax rate (%): 9.187107552969108
Interest coverage ratio: 4.248495435591119
COGS to revenue (%): 90.34212559271214
SG&A to revenue (%): 8.153780212476551
Free cash flow (dilution-adjusted): -317636.7816091954
Retained earnings: 745170.1149425288
Receivables turnover: 3.088712057560284
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.819728278162043
FCF margin (%): -6.894427355499544
Revenue growth (%): -51.897846676202164
Rule of 40 score: -58.79227403170171